ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoimmune diseases. Based in San Francisco next to UCSF Mission Bay, we are funded by DCVC, Foundation Capital and AV8.
www.shennonbio.com
Company Details
- Employees
- 14
- Founded
- -
- Address
- 2325 3rd Street, San Francisco,california 94107,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.shennonbio.com
- Keywords
- Single cell functional profiling, Immunotherapy target discovery, Ultra high throughput analysis, More effective Immunotherapy, Curative treatments for solid tumors.
- HQ
- San Francisco, California
Shennon Biotechnologies Questions
Shennon Biotechnologies's website is https://www.shennonbio.com
Shennon Biotechnologies's LinkedIn profile is https://www.linkedin.com/company/shennon-bio
Shennon Biotechnologies has
14 employees.
View email and phone details for 14
employees at Shennon Biotechnologies.
Shennon Biotechnologies's industry is
Biotechnology Research
Shennon Biotechnologies's top competitors are
Evercrisp Biosciences,
Gate Bioscience,
Tierra Biosciences,
Glycomine Inc.,
Panacro,
Cellmax Life,
Wonderfeel Biosciences,
Karyon Bio,
Marin Biologic Laboratories,
Taxa.
Shennon Biotechnologies's categories are Biotechnology Research
Shennon Biotechnologies's founding year is 2021
